Company / Current Assets
Edgewise Therapeutics, Inc. Current Assets History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$543.4M
FY2025
5-year range
$283.8M / $543.4M
FY2021-FY2025
Trend
+14.3%
vs FY2024
Sector context
#108 of 213
Health Care
What the data says
At $543M, Edgewise Therapeutics, Inc.'s current assets ranks #108 of 213 in the Health Care sector. Improved from $327M to $543M over the past 2 years.
Based on SEC 10-K filings.
$543M in FY2025 with a 5-year CAGR of +33.2%.
Improved from $327M to $543M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +15.0%
- 5-Year CAGR
- +33.2%
- 10-Year CAGR
- -
Sector benchmark
#108 of 213 in Health CareTop 51% of 213This company $543.4M Sector average $2.5B
▼
-78.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +33.2%, indicating consistent growth.
- In FY2025, current assets increased 14.3% year-over-year.
- Ranks #108 out of 213 companies in the Health Care sector.
- Lowest current assets in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 6.82 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $543.4M | +14.3% |
| FY2024 | $475.5M | +45.4% |
| FY2023 | $327.0M | -8.4% |
| FY2022 | $357.0M | +25.8% |
| FY2021 | $283.8M | +118.9% |
| FY2020 | $129.6M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026